GlassScriptPhysician profile
Yoomi Lee
NPI 1720262611
$1,324.27
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,262 · 2020: $43.96 · 2022: $17.95.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $269.75 | 2019 | |
| Pfizer INC. | $131.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $130.73 | 2019 | |
| Genentech USA, INC. | $112.25 | 2019 | |
| Novartis Pharmaceuticals Corporation | $83.92 | 2019 | |
| Astellas Pharma US INC | $51.30 | 2019 | |
| Emd Serono, INC. | $50.44 | 2019 | |
| Ethicon US, LLC | $43.96 | 2020 | |
| Amgen INC. | $36.68 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.37 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $31.00 | 2019 | |
| Seagen INC. | $30.51 | 2019 | |
| Dendreon Pharmaceuticals LLC | $26.86 | 2019 | |
| Taiho Oncology, INC. | $24.52 | 2019 | |
| Mylan Institutional INC. | $23.12 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $23.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.16 | 2019 | |
| Abbvie INC. | $20.70 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.60 | 2019 | |
| Rigel Pharmaceuticals, INC. | $18.05 | 2019 | |
| Beigene USA, INC. | $17.95 | 2022 | |
| Amag Pharmaceuticals, INC. | $16.55 | 2019 | |
| Foundation Medicine, INC. | $15.27 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.69 | 2019 | |
| Agios Pharmaceuticals, INC. | $14.38 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $12.95 | 2019 | |
| Merck Sharp & Dohme LLC | $12.56 | 2019 | |
| Shire North American Group INC | $12.37 | 2019 | |
| Incyte Corporation | $11.97 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $11.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoomi Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.